As of 2024-12-13, the Relative Valuation of ImmunoGen Inc (IMGN) is (5.97) USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.23 USD, the upside of ImmunoGen Inc based on Relative Valuation is -119.1%.
The range of the Relative Valuation is (5.51) - (5.11) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.0x - 31.3x | 26.2x |
| Forward P/E multiples | 19.0x - 19.4x | 19.2x |
| Fair Price | (5.51) - (5.11) | (5.97) |
| Upside | -117.7% - -116.4% | -119.1% |
| Date | P/E |